The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Roche said its Susvimo drug received approval from the U.S. drug regulator for the treatment of diabetic retinopathy, a potentially blinding condition. Susvimo can help people with diabetic ...

Roche: FDA Approves Susvimo for Diabetic Retinopathy Published: May 22, 2025, 12:05 p.m. ET Share Resize ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) 100 mg/mL for ...

A group of advisers to the Food and Drug Administration said Roche Holding AG needs to study its blood cancer treatment in more American patients before its use can be expanded.

Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding several hundred jobs.

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning the President Trump administration for an exemption. | Roche is ...

Roche will invest $50 billion over the next five years for new research and development sites across the US, including a new manufacturing facility in Indiana.

Roche said the investment would go toward high-tech research and development sites and new manufacturing facilities in places including Pennsylvania.

Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, making the pharmaceutical giant the latest company to unveil a capital ...

Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is considering tariffs on drugmakers.